BN Business News
会社を追加 →
この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。

ビジネス · 1995/11/301 分で読めます

Blood Systems Inc., United Blood Services; Revocation of U.S. License No. 183-009

ローカル自動翻訳 · 情報源の原言語

概要

The Food and Drug Administration (FDA) is announcing the revocation of the establishment license (U.S. License No. 183-009) and the product licenses issued to Blood Systems, Inc., United Blood Services, now doing business as Blood Systems, Inc., for the manufacture of Whole Blood, Red Blood Cells, Plasma, Cryoprecipitated antihemophilic factor (AHF), Platelets, and Source Leukocytes. Blood Systems, Inc., United Blood Services has several locations; only the Lubbock, TX, location is affected by this revocation. In a letter to FDA dated June 8, 1994, the firm voluntarily requested revocation of its establishment license and product licenses at the Lubbock, TX, location and thereby waived an opportunity for a hearing.

情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →

関連インサイト

ビジネスインサイト →